• Product NameJujuboside B
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityJujuboside B has potent inhibitory effects on collagen-, thrombin-, AA-, and ADP-induced aggregation, also exhibits superior protection on thromboembolic model.
• Target NameOthers inhibitor
• CAS No. 55466-05-2
• Calculated MW 1045.21
• Formulation C52H84O21
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Cardiovascular System
  SMILES:C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2O[C@H]3CC[C@@]4([C@H]5CC[C@@H]6[C@H]7[C@@](C[C@@H](O[C@@]78C[C@]6([C@@]5(CC[C@H]4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O)O)O)O
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:Soluble in Pyridine, Methanol, Ethanol
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Seo EJ,et al. Zizyphus jujuba and its active component jujuboside B inhibit platelet aggregation. Phytother Res. 2013 Jun;27(6):829-34.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting